11 November 2019

Transactions within the share buy-back program

4 November 2019

Transactions within the share buy-back program

28 October 2019

Transactions within the share buy-back program

21 October 2019

Transactions within the share buy-back program

14 October 2019

Transactions within the share buy-back program

7 October 2019

Transactions within the share buy-back program

2 October 2019

Bioglan will manufacture LECIGON® for Lobsor Pharmaceuticals

30 September 2019

Transactions within the share buy-back program

23 September 2019

Transactions within the share buy-back program

16 September 2019

Transactions within the share buy-back program

9 September 2019

Transactions within the share buy-back program

2 September 2019

Transactions within the share buy-back program

19 August 2019

Transactions within the share buy-back program

5 August 2019

Transactions within the share buy-back program

29 July 2019

Transactions within the share buy-back program

25 July 2019

Reig Jofre closes the first half of 2019 with a sales growth of 3% and EBITDA of 6%

22 July 2019

Reig Jofre starts the first tranche of the second share buyback program

1 July 2019

Reig Jofre acquires Bioibérica’s portfolio of finished pharmaceutical and nutraceutical products, representing a turnover of € 26M

21 June 2019

Start date of trading for the new shares resulting from the capital increase

17 June 2019

Reig Jofre increases its capital amounting to euros 24 million to finance its expansion plan